FDA, BioArray Solutions, International Sequencing Consortium, ABI, Broad Institute, Rockefeller University, British Embassy, Gene Logic, Quest, Correlogic | GenomeWeb

Organizations Call for Genomics — Not
Race — to Guide FDA Approval of BiDil

Anticipating an FDA committee meeting scheduled for this week to discuss the application for the heart failure drug BiDil, a coalition of several organizations this week expressed concern that the treatment has been characterized as "race-specific," and called for additional clinical trials that will take a closer look at the genomic basis for patient response.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.